NCT05314998
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature
Phase: Phase 3
Role: Collaborator
Start: Jan 15, 2025
Completion: Sep 1, 2031